Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANIP
#2064
ANI Pharmaceuticals, Inc.
78.635
0
USD
+0.42%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.42%
Monthly Change
+11.11%
6 month change
-16.90%
Year Change
-16.90%
Previous Close
78.310
0
Open
78.565
0
Bid
Ask
Low
78.565
0
High
78.635
0
Volume
7
Markets
US Stock Market
Healthcare
ANIP
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
12.35 M
17.26 M
17.49 M
21.07 M
21.76 M
22.41 M
—
Valuation ratios
Enterprise value
523.97 M
983.5 M
940.37 M
1.27 B
1.37 B
1.79 B
6.99 B
Price to earnings ratio
-15.45
-13.55
-13.13
67.28
-53.15
23.78
-77.89
Price to sales ratio
1.67
2.69
2.06
2.14
1.74
1.9
7.81
Price to cash flow ratio
22.76
174.72
-20.86
8.75
16.68
9.05
45.65
Price to book ratio
1.78
1.74
2.08
2.4
2.65
3.1
5.7
Enterprise value to EBITDA ratio
23.96
68.32
21.63
19.62
7.92
12.28
63.6
Profitability ratios
Return on assets %
-0.05
-0.06
-0.06
0.02
-0.01
0.05
0.06
Return on equity %
-0.12
-0.13
-0.15
0.04
-0.05
0.14
0.16
Return on invested capital %
-13.62
-22.39
-16.37
26.94
0.23
33.73
34
Gross margin %
58.19
53.45
56.13
62.71
59.27
61.36
246.07
Operating margin %
-7.68
-18.41
-11.15
9.65
0.1
12.58
49.84
EBITDA margin %
21.41
15.49
30.02
35.55
71.25
30
140.79
Net margin %
-10.82
-19.71
-15.14
3.86
-3.01
8.87
34.81
Liquidity ratios
Quick ratio
1.39
2.74
2.4
2.81
2.02
2.19
8.17
Current ratio
2.17
3.68
3.46
3.57
2.72
2.71
10.49
Inventory turnover
—
1.41
1.48
1.68
2.02
2.44
2.42
Asset turnover
0.45
0.35
0.41
0.58
0.56
0.65
0.65
Solvency ratios
Debt to assets ratio
0.37
0.37
0.38
0.32
0.25
0.21
0.89
Debt to equity ratio
0.88
0.86
0.92
0.67
0.78
0.56
2.58
Long term debt to total assets ratio
0.37
0.37
0.38
0.31
0.24
0.2
0.87
Long term debt to total equity ratio
0.88
0.86
0.91
0.66
0.77
0.54
2.55
Per share metrics
Operating cash flow per share
1.28
0.26
-1.92
6.54
3.31
8.73
9
EBIT per share
-1.34
-3.16
-2.17
2.58
0.03
5.23
5.35
EBITDA per share
3.73
2.66
5.84
9.51
22.66
12.48
15.26
Total debt per share
14.44
22.86
17.7
15.97
16.32
14.27
58.7
Cash per share
0.66
7.96
2.97
12.15
7.5
13.45
44.1
Net current asset value per share
14.24
25.55
21.17
28.57
27.32
35.48
125.02
Tangible book value per share
0.3
0.94
2.08
10.75
-10.26
-0.06
-18.84
Working capital per share
7.67
18.6
15.06
20.57
17.29
22.38
77.36
Book value per share
16.36
26.51
19.29
23.79
20.9
25.47
91.84
News
IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results
ANI Pharmaceuticals Stock: Undervalued Cortrophin Drives Rare Disease Growth (NASDAQ:ANIP)
Zacks.com featured highlights include Intuit, ANI Pharmaceuticals and Gaming and Leisure Properties
Is American Well (AMWL) Outperforming Other Medical Stocks This Year?
Insmed Ends Brinsupri Development in Skin Disease Post Study Failure
ANI Pharmaceuticals Stock: Worthy Of A Position (NASDAQ:ANIP)
Kodiak Q4 Loss Wider Than Expected, Pipeline Development in Focus
AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD
AZN Posts Data From Hypophosphatasia Program on Efzimfotase Alfa
ANIP Stock Outlook: Cortrophin Growth vs. Retina Reset
Is ANIP Undervalued? How to Read Its 9.3x Forward P/E
ANI Pharmaceuticals 2026 Watchlist: Gout Sales Force and Rare Disease